RSS feeds allow Web site content to be gathered via feed reader software. Click the subscribe link to obtain the feed URL for this page. The feed will update when new content appears on this page.

Pharmaceutical Industry

A collection of news and information related to Pharmaceutical Industry published by this site and its partners.

Top Pharmaceutical Industry Articles

Displaying items 12-22
  • FDA seeks more data on Acura's abuse-resistant pain drug

    (Reuters) - Acura Pharmaceuticals Inc said the U.S. Food and Drug Administration (FDA) indicated that the company may have to conduct an additional study to determine the abuse-deterrent capability of its experimental painkiller treatment. The FDA in...
  • SEC is investigating bid by Valeant and Bill Ackman for Allergan

    The Securities and Exchange Commission is looking into the way a Canadian pharmaceutical company and activist investor Bill Ackman have tried to buy Botox maker Allergan Inc. of Irvine. Word of the investigation came less than a week after Allergan sued...
  • Allergan seeks deal with Salix to fend off Valeant: WSJ

    (Reuters) - Botox maker Allergan Inc has approached Salix Pharmaceuticals Ltd and at least one other company about a potential takeover in a bid to avert the $53 billion hostile takeover from Valeant Pharmaceuticals International Inc, the Wall Street...
  • Sanford-Burnham taps new CEO from pharma industry

    Sanford-Burnham taps new CEO from pharma industry
    With the selection of Perry Nisen as its new chief executive officer today, Sanford-Burnham Medical Research Institute is signaling a commitment to its new long-term strategic vision of open collaboration for the development of breakthrough clinical...
  • U.S. judge blocks FDA rule allowing generic versions of Hospira drug

    U.S. judge blocks FDA rule allowing generic versions of Hospira drug
    (Reuters) - A federal judge has issued a temporary restraining order against the U.S. Food and Drug Administration's decision to allow the sale of generic versions of the Hospira Inc sedative Precedex. Hospira filed a lawsuit in U.S. District Court in...
  • Glades Drugs opening headquarters in Lake Worth

    Glades Drugs opening headquarters in Lake Worth
    Glades Drugs, a pharmacy retailer owned and operated by pharmacists, is opening new headquarters in Lake Worth. The new 8,000-square-foot location at 4560 Lantana Road will feature office space, a lab and pharmacy. Glades Drugs, now based in Boca Raton,...
  • Cohen, Point72 must face SAC insider trading lawsuit-judge

    NEW YORK (Reuters) - A federal judge rejected billionaire investor Steven A. Cohen's bid to dismiss lawsuits by Elan Corp and Wyeth shareholders who claimed they lost money because his firm SAC Capital Advisors LP conducted insider trading in the...
  • FDA approves Belsomra, a new prescription sleep drug

    FDA approves Belsomra, a new prescription sleep drug
    The Food & Drug Administration on Wednesday approved U.S. marketing of the first in a new class of sleep drugs that targets the brain's wakefulness centers to speed the onset of sleep and reduce nighttime awakening. The new medication, which goes by the...
  • 'Plantibodies' drugs advance as big pharma stands aside

    LOS ANGELES (Reuters) - Biotech drug production techniques based on plants, which may prove to be faster, higher yielding and cheaper than current methods using mammalian cells, haven't caught on with the biggest pharmaceutical companies. The leading...
  • Experimental Ebola drug 'exhausted,' as experts debate ethical use

    As U.S. medical experts raised concerns Tuesday about the use of experimental drugs to treat the Ebola virus, makers of the unapproved medication ZMapp said their supply has been "exhausted." In a statement published online late Monday, Mapp...
  • MannKind agrees to license its inhaled-insulin drug Afrezza to Sanofi

    MannKind agrees to license its inhaled-insulin drug Afrezza to Sanofi
    Less than two months after receiving approval for an inhalable form of insulin, MannKind Corp. agreed to license the drug to Paris-based Sanofi in a deal that could provide the Valencia company with $925 million. Sanofi will initially pay MannKind $150...